Recent Updates
Recently added Catalysts
TLX Positive Sentiment

Telix Announces Board Renewal

Key Takeaway: Telix has announced new Director appointments as part of its Board renewal process, aimed at supporting the company's growth and governance. Tiffany Olson will succeed Kevin McCann as Board Chair, bringing expertise in radiopharmaceuticals. The changes reflect Telix's commitment to enhancing its leadership as it expands globally and prepares for a Nasdaq dual-listing.
Price reaction · baseline $19.5 (2025-02-25 close) · hit after-hours · 2 other TLX headline(s) in the window, move may be shared
day 0 close · peak
-1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • New appointments enhance Board diversity and expertise.
  • Leadership transition aims to support company growth.
  • Positive remarks from outgoing Chairman about the new Chair.
  • CEO expresses gratitude for past leadership and optimism for the future.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease

Full Press Release Details

Melbourne (Australia) | 26 February 2025
Telix today announces new Director appointments as part of a Board succession planning and renewal process.
The Board changes will support the Company’s growth trajectory, expanding global footprint and recent Nasdaq dual-listing. The Board continues to assess the skills and experience needed for strong stewardship and governance and intends to make an additional U.S.-based NED appointment in the near future.
Mr. McCann said, “It has been a great privilege to serve on the Telix Board and contribute to the Company’s success to date. I am grateful to Dr. Behrenbruch and my other fellow Directors for their invaluable support and dedication to Telix’s purpose. I am delighted that the Board has appointed Tiffany to succeed me in the role of Board Chair. She will bring radiopharmaceuticals expertise, energy and strategic insights to the role. Additionally, the appointment of high-caliber Director, Marie McDonald, enhances the diversity of experience within the Board.”
Ms. Olson said, “It is an honor to be succeeding Kevin as the next Chair of Telix. This is a dynamic company with a compelling combination of talent, pipeline and commercial track record, and has an exciting future. I look forward to continuing to work with my fellow Directors and the executive team as we deliver outcomes to patients and shareholders.”
Telix Group CEO and Managing Director, Dr. Christian Behrenbruch added, “We are immensely thankful for Kevin’s outstanding service to Telix as our inaugural Chairman. He has consistently stood for a high standard of corporate governance, a patient-centric company culture and a strong focus on shareholder value creation. Kevin has also been a personal mentor and supporter during a period of extremely rapid growth, for which I am personally grateful. I am very welcoming of Tiffany and Marie’s leadership and what it means for the future trajectory of Telix.”
Read the full ASX release here
[1] Effective, 21 May 2025, immediately following Telix’s Annual General Meeting.
[2] The Board will dissolve the People, Culture, Nomination and Remuneration Committee and establish a new People Committee and Nomination Committee, effective 3 March 2025. Once effective, Committee Charters will be available on Telix’s website.

Frequently Asked Questions

Who is the new Chair of Telix?

Tiffany Olson has been appointed as the new Chair of Telix.

What is the purpose of the Board changes at Telix?

The changes aim to support Telix's growth trajectory and enhance governance.

When will the new Board appointments take effect?

The new appointments will take effect immediately following Telix's Annual General Meeting on 21 May 2025.

What committee changes are being made at Telix?

Telix will dissolve the People, Culture, Nomination and Remuneration Committee and establish new committees effective 3 March 2025.

Last updated: Feb 25, 2025